Gene expression patterns in ovarian carcinomas

被引:135
作者
Schaner, ME
Ross, DT
Ciaravino, G
Sorlie, T
Troyanskaya, O
Diehn, M
Wang, YC
Duran, GE
Sikic, TL
Caldeira, S
Skomedal, H
Tu, IP
Hernandez-Boussard, T
Johnson, SW
O'Dwyer, PJ
Fero, MJ
Kristensen, GB
Borresen-Dale, AL
Hastie, T
Tibshirani, R
van de Rijn, M
Teng, NN
Longacre, TA
Botstein, D
Brown, PO
Sikic, BI [1 ]
机构
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Norwegian Radium Hosp, N-0310 Oslo, Norway
[3] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
关键词
D O I
10.1091/mbc.e03-05-0279
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We used DNA microarrays to characterize the global gene expression patterns in surface epithelial cancers of the ovary. We identified groups of genes that distinguished the clear cell subtype from other ovarian carcinomas, grade I and II from grade III serous papillary carcinomas, and ovarian from breast carcinomas. Six clear cell carcinomas were distinguished from 36 other ovarian carcinomas (predominantly serous papillary) based on their gene expression patterns. The differences may yield insights into the worse prognosis and therapeutic resistance associated with clear cell carcinomas. A comparison of the gene expression patterns in the ovarian cancers to published data of gene expression in breast cancers revealed a large number of differentially expressed genes. We identified a group of 62 genes that correctly classified all 125 breast and ovarian cancer specimens. Among the best discriminators more highly expressed in the ovarian carcinomas were PAX8 (paired box gene 8), mesothelin, and ephrin-B1 (EFNB1). Although estrogen receptor was expressed in both the ovarian and breast cancers, genes that are coregulated with the estrogen receptor in breast cancers, including GATA-3, LIV-1, and X-box binding protein 1, did not show a similar pattern of coexpression in the ovarian cancers.
引用
收藏
页码:4376 / 4386
页数:11
相关论文
共 68 条
  • [61] Modulation of alternative pre-mRNA splicing in vivo by pinin
    Wang, P
    Lou, PJ
    Leu, S
    Ouyang, P
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 294 (02) : 448 - 455
  • [62] Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer
    Welsh, JB
    Zarrinkar, PP
    Sapinoso, LM
    Kern, SG
    Behling, CA
    Monk, BJ
    Lockhart, DJ
    Burger, RA
    Hampton, GM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (03) : 1176 - 1181
  • [63] Identification of genes periodically expressed in the human cell cycle and their expression in tumors
    Whitfield, ML
    Sherlock, G
    Saldanha, AJ
    Murray, JI
    Ball, CA
    Alexander, KE
    Matese, JC
    Perou, CM
    Hurt, MM
    Brown, PO
    Botstein, D
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2002, 13 (06) : 1977 - 2000
  • [64] SEROUS PAPILLARY CARCINOMAS ARISING FROM THE PERITONEUM AND OVARIES - A CLINICOPATHOLOGIC AND IMMUNOHISTOCHEMICAL COMPARISON
    WICK, MR
    MILLS, SE
    DEHNER, LP
    BOLLINGER, DJ
    FECHNER, RE
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1989, 8 (03) : 179 - 188
  • [65] Identification of differentially expressed genes from ovarian cancer cells by MICROMAX™ cDNA microarray system
    Wong, KK
    Cheng, RS
    Mok, SC
    [J]. BIOTECHNIQUES, 2001, 30 (03) : 670 - 675
  • [66] YIN BW, 2001, J BIOL CHEM, V21, P21
  • [67] Arrays of arrays for high-throughput gene expression profiling
    Zarrinkar, PP
    Mainquist, JK
    Zamora, M
    Stern, D
    Welsh, JB
    Sapinoso, LM
    Hampton, GM
    Lockhart, DJ
    [J]. GENOME RESEARCH, 2001, 11 (07) : 1256 - 1261
  • [68] Zeng H, 1999, CANCER RES, V59, P5964